India on Saturday recorded 22,272 new coronavirus cases, pushing the nation’s total tally to 1,01,69,118, in keeping with the information offered by the Union Well being Ministry.
The nation additionally registered 251 new fatalities, taking the loss of life toll to 1,47,343.
As per the ministry, the overall active cases within the nation stand at 2,81,667.
Additionally, with 22,274 new discharges in a span of 24 hours, the overall recoveries have reached 97,40,108.
In the meantime, the Indian Council of Medical Analysis stated 8,53,527 samples have been examined for coronavirus on Friday. The overall variety of samples examined up to now in India are 16,71,59,289.
The nation’s Covid-19 tally had crossed the 20-lakh mark on 7 August, 30 lakh on 23 August, 40 lakh on 5 September, and 50 lakh on 16 September.
The tally went previous 60 lakh on 28 September, 70 lakh on 11 October, crossed 80 lakh on 29 October, 90 lakh on 20 November, and surpassed the one-crore mark on 19 December.
Check out India’s Covid vaccine standing
At current, six Covid-19 vaccines are present process medical trials within the nation and are in several phases of growth. These embody — Covaxin being developed by Bharat Biotech in collaboration with ICMR, second one developed by Zydus Cadila, third one by Gennova, Oxford vaccine, the trial of which is performed by Serum Institute of India, Sputnik V vaccine which is being manufactured by Dr Reddy’s Lab in Hyderabad, in collaboration with Russia’s Gamaleya Nationwide Centre and the sixth one manufactured by Organic E Ltd, Hyderabad, in collaboration with MIT.
Additionally, three coronavirus vaccines have sought emergency use authorisation (EUA) in India. The Pfizer vaccine, which is already getting used for mass vaccination within the US, UK, Canada and some different nations, has sought authorisation in India as nicely. Bharat Biotech and Serum Institute have additionally sought EUA for his or her vaccine candidates.